03.11.2017 20:45:00
|
Niemann-Pick Type C Disease Forecast in 11 Major Markets to 2027 by Gender and 5-Year Age Cohort
DUBLIN, November 3, 2017 /PRNewswire/ --
The "Niemann-Pick Type C Disease Forecast in 12 Major Markets 2017-2027" report has been added to Research and Markets' offering.
Niemann-Pick type C (NP-C) disease is a rare autosomal recessive lysosomal storage disorder with a variety of neurovisceral manifestations. It is caused by mutations in either NPC1 (more common) or NPC2 (less common) genes that lead to accumulation of cholesterol and glycosphingolipids in tissues. NP-C is divided according to the age at onset of symptoms, with an earlier onset of the disease predicting higher severity and poorer prognosis.
This report provides the current prevalent population for Niemann-Pick type C disease across 11 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Japan, China, India, Brazil) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight, subsets and some features of Niemann-Pick type C disease patients, as well as a wide variety of symptoms and co-morbidities have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for Niemann-Pick type C disease include:
- Seizures
- Cataplexy
- Dystonia and tremor
- Spasticity
- Insomnia
- Impaired swallowing
- Cognitive and psychiatric problems
Key Topics Covered:
For more information about this report visit https://www.researchandmarkets.com/research/44tztp/niemannpick_type
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!